Skip to main content
. 2020 Jul 30;12(8):715. doi: 10.3390/pharmaceutics12080715

Figure 3.

Figure 3

Representative (a) Fourier Transform Infrared (FTIR) and (b) Low-Frequency Raman (LFR) spectra of the different particles. From top to bottom: Crystalline kanamycin, kanamycin only formulation (KO), spray-dried tryptophan (Tryptophan_SD), a physical mixture (1:1) of amorphous kanamycin and amorphous tryptophan (PM), kanamycin-tryptophan formulation (KT), kanamycin-valine formulation (KV), kanamycin-methionine formulation (KM), and kanamycin-phenylalanine formulation (KP).